Antibiotic use in patients with COPD receiving EPs 7630 as an add-on treatment;Antibiotikaeinsatz bei COPD-patienten im rahmen einer add-on-therapie mit EPs 7630

Atemwegs- und Lungenkrankheiten

Volumn 41, Issue 1, 2015, Pages 27-34

  Matthys, H ^a,c   Malek, F A ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

^c Lungs at Home   (Germany)

Author keywords

Antibiotic use; COPD; Exacerbations; Herbal drug preparation; Pelargonium sidoides

Indexed keywords

ANTIBIOTIC AGENT; PELARGONIUM SIDOIDES EXTRACT; PLACEBO;

ABSENTEEISM; ADD ON THERAPY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 84924002077     PISSN: 03413055     EISSN: None     Source Type: Journal    
DOI: 10.5414/ATX01973     Document Type: Article

References (21)

1. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000; 117 (Suppl 2): 380S-385S. CrossRef PubMed
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated December 2009. www.goldcopd.com. Accessed August 20, 2010.
3. Vogelmeier C, Buhl R, Criée CP, Gillissen A, Kardos P, Köhler D, Magnussen H, Morr H, Nowak D, Pfeiffer-Kascha D, Petro W, Rabe K, Schultz K, Sitter H, Teschler H, Welte T, Wettengel R, Worth H; Deutsche Atemwegsliga; Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin. Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (Article in German). Pneumologie. 2007; 61: e1-e40. CrossRef PubMed
4. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Verheij TJ; European Respiratory Society; European Society of Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005; 26: 1138-1180. CrossRef PubMed
5. Adams SG, Anzueto A. Antibiotic therapy in acute exacerbations of chronic bronchitis. Semin Respir Infect. 2000; 15: 234-247. CrossRef PubMed
6. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 164: 1618-1623. CrossRef PubMed
7. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987; 106: 196-204. CrossRef PubMed
8. ]Choo C. Combination therapy options in stable COPD. US Pharm. 2010; 35: 31-37.
9. Kolodziej H, Kayser O, Radtke OA, Kiderlen AF, Koch E. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine. 2003; 10 (Suppl 4): 18-24. Cross-Ref PubMed
10. Conrad A, Jung I, Tioua D, Lallemand C, Carrapatoso F, Engels I, Daschner FD, Frank U. Extract of Pelargonium sidoides (EPs® 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. Phytomedicine. 2007; 14 (Suppl 6): 52-59. CrossRef PubMed
11. Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs® 7630. Phytomedicine. 2007; 14 (Suppl 6): 18-26. CrossRef PubMed
12. Agbabiaka TB, Guo R, Ernst E. Pelargonium sidoides for acute bronchitis: a systematic review and meta-analysis. Phytomedicine. 2008; 15: 378-385. Erratum in: Phytomedicine. 2009; 16: 798-799. CrossRef PubMed
13. Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. 2013; 10: CD006323. PubMed
14. Matthys H, Pliskevich DA, Bondarchuk OM, Malek FA, Tribanek M, Kieser M. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD. Respir Med. 2013; 107: 691-701. CrossRef PubMed
15. Rohde GGU. Prudent use of antibiotics: acute exacerbation of COPD as an example. Eur Respir J. 2010; 36: 983-985. CrossRef PubMed
16. American Association for Respiratory Care (AARC). AARC Clinical Practice Guideline. Spirometry, 1996 Update. Respir Care. 1996; 41: 629-636.
17. Roca J, Burgos F, Sunyer J, Saez M, Chinn S, Antó JM, Rodríguez-Roisin R, Quanjer PH, Nowak D, Burney P; Group of the European Community Respiratory Health Survey. References values for forced spirometry. Eur Respir J. 1998; 11: 1354-1362. CrossRef PubMed
18. Bachert C, Schapowal A, Funk P, Kieser M. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology. 2009; 47: 51-58. PubMed
19. Lizogub VG, Riley DS, Heger M. Efficacy of a Pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. Explore (NY). 2007; 3: 573-584. CrossRef PubMed
20. Calverley PMA. Minimal clinically important difference - exacerbations of COPD. COPD. 2005; 2: 143-148. CrossRef PubMed
21. Neugebauer P, Mickenhagen A, Siefer O, Walger M. A new approach to pharmacological effects on ciliary beat frequency in cell cultures - exemplary measurements under Pelargonium sidoides extract (EPs 7630). Phytomedicine. 2005; 12: 46-51. CrossRef PubMed